Thymosin β4 and thymosin β4-derived peptides induce mast cell exocytosis

[1]  H. Kleinman,et al.  Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. , 2005, Trends in molecular medicine.

[2]  D. Srivastava,et al.  Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair , 2004, Nature.

[3]  E. Guittet,et al.  Coupling of Folding and Binding of Thymosin β4 upon Interaction with Monomeric Actin Monitored by Nuclear Magnetic Resonance* , 2004, Journal of Biological Chemistry.

[4]  M. Cavasin,et al.  Prolyl Oligopeptidase Is Involved in Release of the Antifibrotic Peptide Ac-SDKP , 2004, Hypertension.

[5]  G. Pejler,et al.  Human Mast Cell β-Tryptase Is a Gelatinase 1 , 2003, The Journal of Immunology.

[6]  J. Dastych,et al.  Environmentally relevant metal and transition metal ions enhance Fc epsilon RI-mediated mast cell activation. , 2003, Environmental health perspectives.

[7]  H. Kleinman,et al.  Thymosin β4 and a synthetic peptide containing its actin‐binding domain promote dermal wound repair in db/db diabetic mice and in aged mice , 2003 .

[8]  A. Otto,et al.  Thymosin β4 is released from human blood platelets and attached by factor XIIIa (transglutaminase) to fibrin and collagen , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  G. Sosne,et al.  Thymosin ß4 promotes human conjunctival epithelial cell migration , 2002 .

[10]  H. Kleinman,et al.  Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. , 2001, Experimental eye research.

[11]  M. Horsmanheimo,et al.  Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic wounds , 2000, Experimental dermatology.

[12]  E. Bröcker,et al.  Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein‐1 is correlated with recruitment of mast cells which synthesize interleukin‐4 in vivo , 2000, The Journal of pathology.

[13]  H. Kleinman,et al.  Thymosin β4 Accelerates Wound Healing , 1999 .

[14]  D. Metcalfe,et al.  Murine mast cells exposed to mercuric chloride release granule-associated N-acetyl-β-D-hexosaminidase and secrete IL-4 and TNF-α , 1999 .

[15]  M. Artuc,et al.  Mast cells and their mediators in cutaneous wound healing – active participants or innocent bystanders? , 1999, Experimental dermatology.

[16]  M. Lindau,et al.  Mechanism of Peptide-induced Mast Cell Degranulation : Translocation and Patch-Clamp Studies , 1998 .

[17]  S. Ren,et al.  Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. , 1997, The Journal of clinical investigation.

[18]  T. Sosnick,et al.  Thymosin beta 4 binds actin in an extended conformation and contacts both the barbed and pointed ends. , 1997, Biochemistry.

[19]  A. Goldstein,et al.  Thymosin β4 stimulates directional migration of human umbilical vein endothelial cells , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  H. Jörnvall,et al.  Biochemical and antibacterial analysis of human wound and blister fluid. , 1996, European journal of biochemistry.

[21]  S. Muallem,et al.  Actin filament disassembly is a sufficient final trigger for exocytosis in nonexcitable cells , 1995, The Journal of cell biology.

[22]  J. Warner,et al.  A sensitive colorimetric assay for the release of tryptase from human lung mast cells in vitro. , 1993, Journal of immunological methods.

[23]  C. Grillon,et al.  Involvement of thymosin β4 and endoproteinase Asp‐N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic system , 1990, FEBS letters.

[24]  T. Holak,et al.  Solution conformation of thymosin beta 4: a nuclear magnetic resonance and simulated annealing study. , 1990, Biochemistry.

[25]  M. Kampen,et al.  Determination of thymosin β4 in human blood cells and serum , 1987 .

[26]  P. Devillier,et al.  Peptides and histamine release from rat peritoneal mast cells. , 1985, European journal of pharmacology.

[27]  A. Goldstein,et al.  Chemical characterization of thymosin beta 4. , 1982, The Journal of biological chemistry.

[28]  D. Katz,et al.  Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. , 1980, Journal of immunology.

[29]  C. Kitada,et al.  A new mast cell degranulating peptide "mastoparan" in the venom of Vespula lewisii. , 1979, Chemical & pharmaceutical bulletin.

[30]  C. May,et al.  Procedures for immunochemical study of histamine release from leukocytes with small volume of blood. , 1970, The Journal of allergy.

[31]  S. Toda,et al.  Mast cells and angiogenesis , 2003, Microscopy research and technique.

[32]  E. Hannappel,et al.  The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: structure and function. , 2003, Vitamins and hormones.

[33]  Weiqi Huang,et al.  Bone marrow endothelial cells secrete thymosin β4 and AcSDKP , 2001 .

[34]  G. Vanhoof,et al.  Distribution of Prolyl Oligopeptidase in Human Peripheral Tissues and Body Fluids , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[35]  J. Bockaert,et al.  Direct activation of GTP‐binding regulatory proteins (G‐proteins) by substance P and compound 48/80 , 1990, FEBS letters.

[36]  G. Dewald,et al.  Establishment of an immature mast cell line from a patient with mast cell leukemia. , 1988, Leukemia research.

[37]  E. Brzezińska‐Błaszczyk,et al.  Kinetics of specific IgE antibody and total IgE responses in mice: the effect of immunosuppressive treatment. , 1983, International archives of allergy and applied immunology.